This invention discloses a pleiotropic
gene sharing
genetic structure with
obesity and mental disorders, along with its
screening method and applications, belonging to the field of
biomedical technology. The pleiotropic
gene includes RERE, NEGR1, DENND1B, CTNNB1, TMEM106B, SP4, TSNARE1, DENND1A, CNNM2, NT5C2, BMAL1, MPHOSPH9, CCDC92, YLPM1, TAOK2, RTN4RL1, and ARFGEF2. The process includes collecting GWAS summary statistics on
obesity-related phenotypes and mental disorders, assessing genetic correlation, screening pleiotropic genetic loci and candidate pleiotropic genes, using TWAS to screen pleiotropic genes,
functional analysis and
drug target prediction, and bidirectional causal association genetic validation. These methods are used to prepare drugs for the treatment of
obesity and mental disorders or to construct a risk prediction model for obesity-mental disorder
comorbidity.